It sure would be something to hear about SHP-622. As far as the charts I'm LMAO on that one. I had don some research on that Ponezumab trial you posted which I came up with kind of the same as you did.
You keep the good work up cause if we don't dig and figure out what's going on it don't appear we every get a update.
Still say they going to have to raise more capital which in return dilutes us all imo but smart for the ones buying. They paying pennies on the dollar which is really a smart business move on there part and they know what's ongoing and what's occurred they in the loop.
News 
Market Data 
Discover 
AI
